openPR Logo
Press release

HERG Screening Market Segments, Analysis, Overview, Outlook Report 2024-2033

HERG Screening Market Segments

HERG Screening Market Segments

The Business Research Company recently released a comprehensive report on the Global HERG Screening Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The HERG screening market size has grown rapidly in recent years. It will grow from $1.42 billion in 2023 to $1.62 billion in 2024 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to increasing drug development activities, regulatory requirements, increasing awareness of cardiac safety, rising incidence of cardiac disorders.

The HERG screening market size is expected to see rapid growth in the next few years. It will grow to $2.60 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to expansion of personalized medicine, increasing outsourcing of drug development activities, emerging markets and research, focus on non-cardiac safety assessments. Major trends in the forecast period include advanced in vitro models, integration of genomic and proteomic data, advancements in computational approaches, focus on pediatric drug safety, collaborations for data sharing and standardization.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/herg-screening-global-market-report

Market Drivers and Trends:

The rise in the number of patients with heart disorders is expected to propel the growth of the HERG screening market going forward. Heart disorders, also known as cardiovascular disorders or diseases, refer to a range of conditions that affect the heart and blood vessels. These conditions can impact the heart's ability to function properly and may lead to serious health complications. These disorders arise because of unhealthy lifestyles, an aging population, genetic factors, diabetes, and metabolic syndrome. HERG screening helps to identify potential drug candidates, prevent adverse cardiac events that could induce life-threatening cardiac arrhythmias, particularly torsade de pointes (TdP), and improve patient outcomes. For instance, in May 2023, the Centers for Disease Control and Prevention., a US-based national public health agency, reported that in the US, 1 in 20 adults age 20 and older have cardiovascular diseases, 695,000 people were suffering from cardiovascular diseases in 2021, and 375,476 people died with cardiovascular diseases that same year. Furthermore, in March 2022, according to a report published by the Office for National Statistics, a UK-based government department, 19,440 people died of heart attacks in 2020, and this number increased to 20,061 in 2021. Therefore, the rise in the number of patients with heart disorders is driving the growth of the HERG screening market.

Major companies operating in the HERG screening market are concentrating on new innovative advanced solutions, such as GLP-certified HERG screening services, to enhance cardiac safety assessments during drug development processes. This service refers to the good laboratory practice-certified screening of the human ether-à-go-go related gene (hERG) using the conventional whole-cell patch-clamp technique. It ensures that the screening is conducted in compliance with regulatory guidelines such as ICH S7A and ICH S7B, which are essential for safety pharmacology studies in drug development. For instance, in August 2023, Metrion Biosciences Ltd., a UK-based pharmaceutical company, launched the good laboratory practice (GLP)-certified hERG screening service. This service aims to enhance Metrion's support for small-molecule therapeutic development and complement the company's existing cardiac safety service portfolio. Additionally, this service utilizes the conventional whole-cell patch-clamp technique to assess potential cardiac liabilities before entering Phase 1 clinical trials in humans, provides regulatory guidance for safety pharmacology studies in drug development, and offers clients high-quality biology services for ion channel targets.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=14392&type=smp

Major Key Players of the Market:

Eurofins-Cerep SA., Aviva Biosciences Inc., AstraZeneca Public Limited Company, Merck KGaA, Charles River Laboratories Inc., Abcam Public Limited Company, Molecular Devices LLC, Caliper Life Sciences Inc., Crprotex Limited, ChanTest Corporation, Creative bioarray Inc., Cellular Dynamics International Inc., Nanion Technologies, Essen Bioscience, ABR-Affinity BioReagents Inc., ACEA Biosciences Inc., Metrion biosciences Inc., Aurora Biomed Inc., Aureus Sciences, RedShift BioAnalytics, B'SYS GmbH, Cambridge Bioscience Ltd., Sophion Bioscience Inc., Fluxion Biosciences Inc., ChemAxon Ltd.

HERG Screening Market 2024 Key Insights:

• The HERG Screening Market is expected to grow to $2.60 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%.
• Expanding HERG Screening Market Fueled By Increasing Prevalence Of Heart Disorders
• Metrion Biosciences Ltd. Introduces GLP-Certified hERG Screening Service For Enhanced Cardiac Safety In Drug Development
• North America was the largest region in the HERG screening market in 2023. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the HERG screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=14392&type=smp

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

Contact Us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HERG Screening Market Segments, Analysis, Overview, Outlook Report 2024-2033 here

News-ID: 3686262 • Views:

More Releases from The Business research company

What Are the Key Opportunities and Trends Shaping the Future of the Global Zinc Battery Market (2024-2033)?
What Are the Key Opportunities and Trends Shaping the Future of the Global Zinc …
The zinc battery market report describes and explains the zinc battery market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and for the major economies within each region. The global zinc battery market reached a value of nearly $920.00 million in 2023, having grown at a compound annual growth rate (CAGR) of 11.96% since 2018. The market
What Are the Key Opportunities and Trends Shaping the Future of the Global Neurovascular Embolization Devices Market (2024-2033)?
What Are the Key Opportunities and Trends Shaping the Future of the Global Neuro …
The neurovascular embolization devices market report describes and explains the neurovascular embolization devices market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and the major economies within each region. The global neurovascular embolization devices market reached a value of nearly $1,243.49 million in 2023, having grown at a compound annual growth rate (CAGR) of 3.12% since 2018.
How Drone Adoption is Powering Up the Drone Battery Market in 2024: Key Drivers and Trends in Commercial and Defense Applications
How Drone Adoption is Powering Up the Drone Battery Market in 2024: Key Drivers …
The Drone Battery report describes and explains the drone battery market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and the major economies within each region. The global drone battery market reached a value of nearly $4.98 billion in 2023, having grown at a compound annual growth rate (CAGR) of 14.32% since 2018. The market is expected
A Comprehensive Overview of Cloud Manufacturing Market (2024-2033)
A Comprehensive Overview of Cloud Manufacturing Market (2024-2033)
The cloud manufacturing market report describes and explains the cloud manufacturing market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and the major economies within each region. The global cloud manufacturing market reached a value of nearly $73,706.35 million in 2023, having grown at a compound annual growth rate (CAGR) of 15.62% since 2018. The market is

All 5 Releases


More Releases for HERG

Herg Screening Market New Innovations, Developments and Research 2021 to 2026
The Global Herg Screening Market Research Report 2021-2026 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report. Top Companies
Herg Screening Market 2019-2024: Size, Share, Growth, Application, Regional Dema …
Global Herg Screening market report offers in-depth knowledge and analysis results and knowledge concerning Herg Screening market share, growth factors, size, key drivers, restraints, opportunities, and trends valid by a mixture of specialists with correct data of the precise trade and Herg Screening market further as region-wise analysis experience. The Herg Screening report contains historical, current, and projected revenues for every sector, segment, Herg Screening end-use phase, and region. Get Sample
The global automotive central lubricating system market is anticipated to expand …
Product Overview The automotive central lubrication system is used to deliver specific amount of lubricant at different location in machine. It is supplied to moving parts of the machine especially bearings in order to reduce friction. The automotive central lubrication system increases the efficiency and reduces the functioning time of the machine. The proper greasing at specific parts of the machine reduces the maintenance cost. The fully automated system requires less
Global Automotive Central Lubricating System Market Analysis & Growth Opportunit …
Automotive Central Lubricating System Market: Global Demand Analysis & Opportunity Outlook 2027 The automotive central lubricating system is an automatic system of lubricating the vital machine parts. The numerous parts of the automatic central lubrication system include controller, pump with reservoir, supply line, metering valves and feed lines. It is applied in small and measured amount to the machinery. The global automotive central lubricating system market can be segmented into lubrication
Global HERG Screening Market Analysis 2018 Forecasts To 2023
HERG Screening Industry Description Wiseguyreports.Com Adds “HERG Screening -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database hERG Screening Market research report presents an in depth analysis of hERG Screening market. The study emphasizes on both technology and product segments of hERG Screening in biotechnology and pharmaceutical application areas. The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts,
Cytocentrics is proud to announce the appointment of SciPro as their new distibu …
Cytocentrics Bioscience GmbH, inventors of Cytocentering technology for automated patch clamp, is proud to announce the appointment of SciPro Inc. as their distribution partner for the CytoPatch2 in North America. (Rostock ) - Germany, March 26, 2013. Graeme Daniels, Sales Director at Cytocentrics, said “We are extremely happy to have found a company of SciPro’s calibre to work with to bring our new CytoPatch2 automated patch clamp system to